Strassburger C. Philip's most recent trade in Ocular Therapeutix Inc was a trade of 175,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ocular Therapeutix Inc | Strassburger Philip C. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Ocular Therapeutix Inc | Strassburger C. Philip | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 58,304 | 167,522 (0%) | 0% | 0 | Common Stock | |
Ocular Therapeutix Inc | Philip Strassburger C. | General Counsel | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 6,029 | 161,493 (0%) | 0% | 4.9 | 29,301 | Common Stock |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 6,831 | 109,218 (0%) | 0% | 4.9 | 33,813 | Common Stock |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 6,181 | 109,071 (0%) | 0% | 4.2 | 26,207 | Common Stock |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 55,556 | 115,252 (0%) | 0% | 0 | Common Stock | |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 50,000 | 51,810 (0%) | 0% | 0 | Common Stock | |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 51,900 | 51,900 | - | - | Stock Option (Right to Buy) | |
Ocular Therapeutix Inc | Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) |